Skip to main content

Table 3 SF12, FSS and mMRC scores comparison at 6 and 12 months follow up between severe and non-severe respiratory status at inclusion

From: Fatigue and quality-of-life in the year following SARS-Cov2 infection

 

Severea

Non-severeb

p value

6 months (N)

42

78

 

 SF12

   

  PCS12 (mean ± SD)

42.7 ± 9.7

42.9 ± 10.2

0.87

  MCS12 (mean ± SD)

46.6 ± 7.8

46.7 ± 7.5

0.87

 FSS

   

 (Mean ± SD)

29.8 ± 17.0

31.4 ± 16.9

0.64

 mMRC

   

 (Median, Q1–Q3)

1, 0–1.8

1, 0–2

0.67

12 months (N)

42

78

 

 SF12

   

  PCS12 (mean ± SD)

42.2 ± 9.1

42.2 ± 9.8

0.92

  MCS12 (mean ± SD)

48.0 ± 6.4

46.7 ± 6.4

0.16

 FSS

   

 (Mean ± SD)

29.5 ± 17.1

34.0 ± 17.9

0.22

 mMRC

   

 (Median, Q1–Q3)

1, 0–1

1, 0–2

0.45

  1. aIncludes severe initial pneumonia and acute respiratory distress syndrome (ARDS). Criteria for severe pneumonia were: fever and SpO2 < 90% or respiratory rate > 30/min or acute respiratory failure needing respiratory support (invasive or not) and/or admission in ICU and/or acute circulatory failure (sepsis or septic shock)
  2. bIncludes respiratory symptoms without identified pneumonia
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us